Zevra Therapeutics Inc. Capital Reinvestment Ratio
Zevra Therapeutics Inc. capital reinvestment ratio. Zevra Therapeutics Inc. (ZVRA) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow ($4.71 Million) in capital expenditures ($554.00K). Check ZVRA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zevra Therapeutics Inc. (2021–2021)
Capital reinvestment ratio of Zevra Therapeutics Inc. from 2021 to 2021. This chart tracks Zevra Therapeutics Inc.'s Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Zevra Therapeutics Inc. to track the company's year-over-year net asset growth rate.
Zevra Therapeutics Inc. Capital Reinvestment Ratio by Year (2021–2021)
Zevra Therapeutics Inc. capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see ZVRA operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | $10.44 Million | $102.00K | — |